Mucins and Pancreatic Cancer

Pancreatic cancer is characterized by an often dramatic outcome (five year survival < 5%) related to a late diagnosis and a lack of efficient therapy. Therefore, clinicians desperately need new biomarkers and new therapeutic tools to develop new efficient therapies. Mucins belong to an ever i...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Isabelle Van Seuningen, Nicolas Skrypek, Nicolas Jonckheere
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI AG 2010-10-01
Serie:Cancers
Soggetti:
pancreatic cancer
mucin
regulation
biomarker
therapy
Accesso online:http://www.mdpi.com/2072-6694/2/4/1794/
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi